Medicinal Plants Classification Biosynthesis and ... - Index of

Recommendations

Info

Native Medicinal Plants used in the Ethnomedicine of the Córdoba Hills... Figure 1. Geographical location of the study area, belonging to the following four regions of the province of Córdoba: 1) Northern Region: Cerro Colorado, Departament of Tulumba. 2) Southwest Córdoba: Sierras de Comechingones; 3) Region of Paravachasca and Calamuchita in the Sierras Chicas of Córdoba; 4) Western Region: ―El Diquecito‖ Department of Colón. 57
58 [2] Gustavo J. Martínez, Mara Sato and Marta Ojeda (1) Northern Region: the information gathered by Menseguez et al. (2007) and Arias Toledo (2006) is referred to the Department of Tulumba in the Cerro Colorado area, which has a characteristic Chaco Serrano vegetation. (2) Sierras de Comechingones Region, Southwest Córdoba: based on an ethnobotanic study performed in the Comechingones hills (Chaqueño District) in the limit with the Province of San Luis (Goleniowski et al., 2006). (3) Region of the southern hills and valleys: based on investigations carried out in the valleys of Paravachasca and Calamuchita in the Sierras Chicas of Córdoba (Martínez, 2003, 2005b; 2007; 2008a,b; Martínez & Planchuelo, 2003; Arias Toledo et al., 2007). (4) Western Region: based on information from the locality of ―El Diquecito‖, to the west of the city of Córdoba, in the Department of Colón. This is a semi-rural hilly area that is progressing towards urban characteristics. Although the ethnobotanical information is scarce, fragmented and still has to be systematized, we considered preliminary data obtained in a participative project in a rural school (Salguero & Asad, 2006). A comparison of the medical uses and applications was performed between the different regions following the criteria of intercultural comparison proposed by Heinrich et al. (1998). The following estimations were made using quantitative indicators: – Recurrence of a specific medicinal use or application of a plant in the different regions of Córdoba considered in the study. – Inter-regional agreement on different categories of medicinal use for the most cited species, evaluated by the Informant Consensus Factor (Fic) according to the following formula: Fic= (nur-nt)/(nur-1) where nur is the number of use-reports in each category; nt is the number of taxa used; and nur is the number of use-reports in each category. This factor ranges from 0 to 1, where a high value (near 1) indicates that relatively few species are used by a large proportion of informants and a low value indicates that the informants disagree on the taxa used in the treatments of a certain illness category (Heinrich et al., 1998). III. Taking into account the distribution, ecology, habitat and origin of the implicated medicinal species, as well as information on their harvest, extraction, use and commercialization, we suggest methodological and technical considerations as well as practices destined to the in situ and ex situ conservation of medicinal flora.
Page 2 and 3:
BIOTECHNOLOGY IN AGRICULTURE, INDUS
Page 4:
Industrial Biotechnology Shara L. A
Page 7 and 8:
Copyright © 2009 by Nova Science P
Page 9 and 10:
viii Contents Chapter 8 Pharmacolog
Page 11 and 12:
x Alejandro Varela and Jasiah Ibañ
Page 13 and 14:
xii Alejandro Varela and Jasiah Iba
Page 15 and 16:
xiv Alejandro Varela and Jasiah Iba
Page 18 and 19:
In: Medicinal Plants: Classificatio
Page 20 and 21:
Biological Effects of -Carotene acy
Page 22 and 23:
Biological Effects of -Carotene cry
Page 24 and 25: Biological Effects of -Carotene ris
Page 26 and 27: Biological Effects of -Carotene Whe
Page 28 and 29: Biological Effects of -Carotene fla
Page 30 and 31: Biological Effects of -Carotene Pre
Page 32 and 33: Biological Effects of -Carotene A (
Page 34 and 35: Biological Effects of -Carotene As
Page 36 and 37: Biological Effects of -Carotene car
Page 38 and 39: Biological Effects of -Carotene res
Page 40 and 41: Biological Effects of -Carotene the
Page 42 and 43: Biological Effects of -Carotene cat
Page 44 and 45: Biological Effects of -Carotene mos
Page 46 and 47: Biological Effects of -Carotene dia
Page 48 and 49: Biological Effects of -Carotene veg
Page 50 and 51: Biological Effects of -Carotene .Su
Page 52 and 53: Biological Effects of -Carotene Bat
Page 54 and 55: Biological Effects of -Carotene Dah
Page 56 and 57: Biological Effects of -Carotene Hal
Page 58 and 59: Biological Effects of -Carotene Kva
Page 60 and 61: Biological Effects of -Carotene Osh
Page 62 and 63: Biological Effects of -Carotene San
Page 64: Biological Effects of -Carotene Van
Page 67 and 68: 50 Gustavo J. Martínez, Mara Sato
Page 73: 56 Gustavo J. Martínez, Mara Sato
Page 89 and 90: Huperzia saururus (Lam.) Trevis. Mi
Page 95 and 96: PNEUMONOLOGY AND INFECTIOUS DISEASE
Page 115 and 116: 98 Aracely E. Chávez-Piña and And
Page 117 and 118: 100 Aracely E. Chávez-Piña and An
Page 125 and 126:
108 Aracely E. Chávez-Piña and An
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
118 HO HO HO HO HO HO OH OH M e Me
Page 137 and 138:
120 Me Me OH Me O OH O O OH H Me OH
Page 139 and 140:
122 HO HO HO Aracely E. Chávez-Pi
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
140 Hua-Bin Li, Dan Li, Ren-You Gan
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
152 6.4. Antibacterial Effects Hua-
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
168 Vandana Gulati, Ian H. Harding
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 206 and 207:
In: Medicinal Plants: Classificatio
Page 208 and 209:
Biomolecules with Anti-Mycobacteria
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218:
Page 221 and 222:
204 Chien-Yi Chen Ligusticum chuanx
Page 223 and 224:
206 Chien-Yi Chen (IAEA 336), also
Page 225 and 226:
208 Chien-Yi Chen 4. Results and Di
Page 227 and 228:
210 4.3. Fresh Leaves and Stems Chi
Page 229 and 230:
212 Chien-Yi Chen collected from na
Page 231 and 232:
214 Chien-Yi Chen primary enzyme in
Page 233 and 234:
216 Chien-Yi Chen [20] Liu SM, Chun
Page 235 and 236:
218 S.M.M. Vasconcelos, J.E.R. Hon
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
244 Sônia Sin Singer Brugiolo, Luc
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
256 C.W. Huck and G.K. Bonn Keyword
Page 275 and 276:
258 C.W. Huck and G.K. Bonn No addi
Page 277 and 278:
260 C.W. Huck and G.K. Bonn The rob
Page 279 and 280:
262 C.W. Huck and G.K. Bonn Validat
Page 281 and 282:
264 Naphthodianthrones C.W. Huck an
Page 283 and 284:
266 C.W. Huck and G.K. Bonn Figure
Page 285 and 286:
268 C.W. Huck and G.K. Bonn Figure
Page 287 and 288:
270 C.W. Huck and G.K. Bonn hierarc
Page 289 and 290:
272 C.W. Huck and G.K. Bonn [17] Hu
Page 292 and 293:
In: Medicinal Plants Classification
Page 294 and 295:
What is the Future of Phytotherapy?
Page 296 and 297:
In: Medicinal Plants Classification
Page 298 and 299:
Quality Control of Polysaccharides
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Origins Targets Neisseria meningiti
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330:
Page 333 and 334:
316 Philippe N. Okusa, Caroline Ste
Page 335 and 336:
Page 337 and 338:
320 2.7. General Toxicity Tests Phi
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
338 age-related macular degeneratio
Page 357 and 358:
340 B lymphocytes, 7 babies, 60, 62
Page 359 and 360:
342 cell surface, 229 cellular adhe
Page 361 and 362:
344 cultivation, 75, 76, 83, 85, 14
Page 363 and 364:
346 embryonic stem cells, 47 emotio
Page 365 and 366:
348 gas, xiii, 21, 104, 131, 145, 1
Page 367 and 368:
350 high-performance liquid chromat
Page 369 and 370:
352 institutions, 84 instruments, 2
Page 371 and 372:
354 lung, ix, 1, 6, 16, 17, 22, 23,
Page 373 and 374:
356 mucosa, x, 2, 19, 97, 98, 99, 1
Page 375 and 376:
358 oxidative, 4, 8, 9, 10, 12, 13,
Page 377 and 378:
360 polyunsaturated fatty acids, 10
Page 379 and 380:
362 Reserpine, 328 reservation, 143
Page 381 and 382:
364 SPT, 135 squamous cell carcinom
Page 383 and 384:
366 transcription, 8, 35, 152 trans
show all

Medicinal Plants Classification Biosynthesis and ... - Index of

Create successful ePaper yourself

Delete template?

Save as template?